Effect of the antimicrobial peptide D-Nal-Pac-525 on the growth of Streptococcus mutans and its biofilm formation

Journal of Microbiology and Biotechnology

Volumn 23, Issue 8, 2013, Pages 1070-1075

  Li, Huajun ^a   Cheng, Jya Wei ^b   Yu, Hui Yuan ^b   Xin, Yi ^a   Tang, Li ^a   Ma, Yufang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial peptides; Biofilm; D Nal Pac 525; Streptococcus mutans

Indexed keywords

DEXTRO NAPHTHYALANINE PAC 525 PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BIOFILM; CONTROLLED STUDY; GROWTH INHIBITION; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS MUTANS; TRANSMISSION ELECTRON MICROSCOPY;

ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; STREPTOCOCCUS MUTANS;

EID: 84882999973     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1212.12035     Document Type: Article

References (26)

1. Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D, et al. 2007. Activity of an antimicrobial peptide minetic against planktonic and biofilm culture of oral pathogens. Antimicrob. Agents Chemother. 51: 4125-4132.
2. Chastre J. 2008. Evolving problems with resistant pathogens. Clin. Microbiol. Infect. 14: 3-14.
3. Clinical and Laboratory Standards Institute. 2005. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA.
4. Elbaz M, Ben-Yehua S. 2010. The metabolic enzyme ManA reveals a link between cell wall integrity and chromosome morphology. PloS Genet. 6: e1001119.
5. Hancock RW, Patrzykat A. 2002. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2: 79-83.
6. Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R. 2010. D-Amino acids trigger biofilm disassembly. Science 328: 627-629.
7. Lemos JA, Abranches J, Burne RA. 2005. Responses of cariogenic streptococci to environmental stresses. Curr. Issues Mol. Biol. 7: 95-107.
8. Liu H, Du Y, Wang X, Sun L. 2004. Chitosan kills bacteria through cell membrane damage. Int. J. Food Microbiol. 95: 147-155.
9. Liu N, Chen XG, Park HJ, Liu CG, Liu CS, Meng XH, et al. 2006. Effect of MW and concentration of chitosan on antibacterial activity of Escherichia coli. Carbohydr. Polym. 64: 60-65.
10. Liu Y, Wang L, Zhou X, Hu S, Zhang S, Wu H. 2011. Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm. Int. J. Antimicrob. Agents 37: 33-38.
11. Marsh PD. 2003. Are dental diseases examples of ecological catastrophes? Microbiology 149: 279-294.
12. Merrifield EL, Mitchell SA, Ubach J, Boman HG, Andreu D, Merrifield RB. 1995. D-Enantiomers of 15-residue cecropin A-melittin hybrids. Int. J. Pept. Protein Res. 46: 214-220.
13. Oren Z, Ramesh J, Avrahami D, Suryaprakash N, Shai Y, Jelinek R. 2002. Mode of membrane interaction and structure in micelles of a short a-helical lytic peptide and its diastereomer determined by NMR, FTIR, and fluorescence spectroscopy. Eur. J. Biochem. 269: 3869-3880.
14. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, et al. 2001. Bacterial diversity in human subgingival plaque. J. Bacteriol. 183: 3770-3783.
15. Petersen PE. 2003. The World Oral Health Report 2003: continuous improvement of oral health in the 21st century -the approach of the WHO Global Oral Health Programme. Community Dent. Oral. Epidemiol. 31: 3-24.
16. Raj PA, Antonyraj KJ, Karunakaran T. 2000. Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem. J. 347: 633-641.
17. Russell RR. 2008. How has genomics altered our view of caries microbiology? Caries Res. 42: 319-327.
18. Stepanovic S, Cirkovic I, Ranin L, Svabic-Vlahovic M. 2004. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface. Lett. Appl. Microbiol. 38: 428-432.
19. Wei GX, Campagna AN, Bobek LA. 2006. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J. Antimicrob. Chemother. 57: 1100-1109.
20. Wilson M. 1996. Susceptibility of oral bacterial biofilms to antimicrobial agents. J. Med. Microbiol. 44: 79-87.
21. Wu JM, Wei SY, Chen HL, Weng KY, Cheng HT, Cheng JW. 2007. Solution structure of a novel D-β-naphthylalanine substituted peptide with potential antibacterial and antifungal activities. Peptide Sci. 88: 738-745.
22. Yeaman MR, Nannette YY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55: 27-55.
23. Yu HY, Tu CH, Yip BS, Chen HL, Cheng HT, Huang KC, et al. 2011. Easy strategy to increase salt resistance of antimicrobial peptides. Antimicrob. Agents Chemother. 55: 4918-4921.
24. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
25. Wei SY, Wu JM, Kuo YY, Chen HL, Yip BS, Tzeng SR, et al. 2006. Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J. Bacteriol. 188: 328-334.
26. Wang CW, Yip BS, Cheng HT, Wang AH, Chen HL, Cheng JW, et al. 2009. Increased potency of a novel D-beta-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens. FEMS Yeast Res. 9: 967-970.